Point72 Asia (Singapore)’s Dianthus Therapeutics DNTH Stock Holding History

Point72 Asia (Singapore)’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$118K	Buy	3,004 +1,990	+196%	+$50.9K	0.02%	408
2025 Q2	$18.9K	Buy	+1,014	New	+$19K	﹤0.01%	737
2024 Q4	–	Sell	-8,568	Closed	-$235K	–	950
2024 Q3	$235K	Sell	8,568 -30,936	-78%	-$862K	0.04%	333
2024 Q2	$1.02M	Buy	39,504 +29,159	+282%	+$701K	0.21%	96
2024 Q1	$310K	Buy	+10,345	New	+$225K	0.08%	272

Other funds holding DNTH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asia (Singapore)'s DNTH Position: Q3 2025 in Review

Point72 Asia (Singapore) increased its Dianthus Therapeutics (DNTH) stake by 196% in Q3 2025, buying an estimated $50.9K and bringing the position to 3,004 shares worth $118K. The position accounts for 0.02% of the portfolio, ranked #408.

Point72 Asia (Singapore) first reported a position in DNTH in Q1 2024 and has held it in 5 quarters since. The position peaked at $1.02M in Q2 2024. 140 funds tracked by Wall St. Rank hold DNTH as of Q3 2025.

Point72 Asia (Singapore) held 3,004 shares of Dianthus Therapeutics worth $118K as of Q3 2025.
Point72 Asia (Singapore) bought 1,990 Dianthus Therapeutics shares in Q3 2025, an estimated $50.9K.
Dianthus Therapeutics made up 0.02% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #408 holding.
Point72 Asia (Singapore) first reported a position in Dianthus Therapeutics in Q1 2024 and has held it in 5 quarters since.
Point72 Asia (Singapore)'s Dianthus Therapeutics position peaked at $1.02M in Q2 2024.
140 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.